ArticleThe Journal of dermatology2026

Real-World Safety Profile of Spesolimab in Generalized Pustular Psoriasis: Insights From Japan as Part of a Multinational Expanded Access Program (EAP).

Akimichi Morita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.